Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea
DESALT
The Effect of Sodium-Restricted Diet and Diuretic in the Severe Sleep Apnea: a Randomized Controlled Trial - DESALT Study
2 other identifiers
interventional
54
1 country
1
Brief Summary
This study evaluates the intervention of the 1) sodium-restricted diet, or 2) diuretic, or 3) placebo pill in the treatment of obstructive sleep apnea in adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Oct 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2013
CompletedFirst Posted
Study publicly available on registry
September 19, 2013
CompletedStudy Start
First participant enrolled
October 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedAugust 20, 2015
August 1, 2015
1.3 years
September 16, 2013
August 19, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Apnea-Hypopnea Index
Number of apneas/hour
One week
Secondary Outcomes (5)
Somnolence scale (Epworth) and ventilatory parameters
One week
Glycolipid profile
One week
Aldosterone Renin Level Activity
One week
Dosages of urinary 24h
One week
Inflammatory marker
One week
Study Arms (3)
Lasilactone
ACTIVE COMPARATORDosage form: One capsule taking in the morning Dosage: furosemide, 20mg, and spironolactone, 100 mg. Frequency and duration: One capsule daily for 7 days.
placebo pill
PLACEBO COMPARATOROne capsule taking in the morning. Frequency and duration: One capsule daily for 7 days.
Sodium-Restricted Diet
ACTIVE COMPARATORThe diet group will receive a regimen with a prescribed intake of three grams of sodium per day
Interventions
Active drug (spironolactone 100 mg plus furosemide 20 mg).
The sodium-restricted diet will enforce some rules: do not use salt in cooking; do not use the salt shaker; do not ingest any industrialized food; to eat fresh salads and vegetables; do not add high-sodium seasonings, among others. The complete dietary rules will be delivered to each volunteer in a four page handout.
The placebo group will receive cellulose-based placebo pills with identical pills and flasks to active drug.
Eligibility Criteria
You may qualify if:
- Men in the age range from 18 to 60 years
- Full-night in-laboratory polysomnography with apnea-hypopnea index \> 30/h in the last three months
- Body mass index \< 35 kg/m2
- Informed consent
You may not qualify if:
- Already having started any treatment for sleep apnea, including use of continuous positive airway pressure
- NYHA heart failure, any class
- Predominantly central apnea
- Peripheral venous or lymphatic insufficiency
- Any chronic renal disease
- Use of diuretics and substances with action in the central or peripheral nervous system such as benzodiazepines, hypnotics, anticonvulsants, antidepressants, appetite suppressants, amphetamines, antiparkinson agents, muscle relaxants, bronchodilators
- Stroke within 6 months or with incapacitating sequelae
- Any physical, mental or social condition impairing the ability to participate in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
Related Publications (2)
Fiori CZ, Martinez D, Montanari CC, Lopez P, Camargo R, Sezera L, Goncalves SC, Fuchs FD. Diuretic or sodium-restricted diet for obstructive sleep apnea-a randomized trial. Sleep. 2018 Apr 1;41(4). doi: 10.1093/sleep/zsy016.
PMID: 29669139DERIVEDFiori CZ, Martinez D, Goncalves SC, Montanari CC, Fuchs FD. Effect of diuretics and sodium-restricted diet on sleep apnea severity: study protocol for a randomized controlled trial. Trials. 2015 Apr 25;16:188. doi: 10.1186/s13063-015-0699-9.
PMID: 25906818DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Denis Martinez, MD, PhD
Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2013
First Posted
September 19, 2013
Study Start
October 1, 2013
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
August 20, 2015
Record last verified: 2015-08